Partner With the 2nd Tumor Myeloid-Directed Therapies Summit
Gather in person for the first time to communicate your exciting progress to the decision-makers in the field, generate leads, and understand what next-generation investments the market wants, you can rely on our ability to advise and deliver the right solution for you.
Join us in June to elevate your brand and demonstrate your expertise in this growing field.
- Preclinical, Formulation & Toxicology Services –provide drug developers with insight into how to prime themselves for clinical trials. How can they achieve an optimal formulation and effectively test drug safety?
- Clinical Development – highlight how you are accelerating and supporting clinical development and position yourself as the leading clinical research organization in the space
- Equipment and Servicing – showcase why developers should come to you to fulfil their equipment needs and ensure you’re perceived as the leading provider
Bump elbows with the who’s who of Myeloid biology and make lasting connections with senior level decisionmakers from leading pharma and biotech companies
Drive your brand and position yourself as the partner of choice in this exploding field to differentiate yourself from competitors
Demonstrate subject matter expertise in immune-oncology preclinical to clinical development, from single cell analysis to clinical trial design
Embrace in-person networking again to meet your 2022 commercial objectives and support therapeutic development through the Myeloid compartment
Attendance by Company Type
Delegate Seniority Breakdown
For more information on our highly engaged audience, request a blind delegate list.
